News

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk

9 December 2022

Prostate cancer is the most common type of cancer in men. According to Cancer Research UK, over 52,000 men are diagnosed with the disease each year and there are more than 12,000 deaths. Now, Cambridge scientists have created a new, comprehensive tool for predicting an individual’s risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive the appropriate testing while reducing unnecessary – and potentially invasive – testing for those at very low risk.

Rebecca Fitzgerald receives Innovation and Entrepreneurship award

Rebecca Fitzgerald receives Cancer Research Horizons Innovation and Entrepreneurship Award

7 December 2022

Congratulations to Early Cancer Institute Director, Professor Rebecca Fitzgerald, who has been awarded an Impact Recognition Award by Cancer Research Horizons. The awards recognise the UK’s most innovative and enterprising efforts in oncology. The judges of the Impact Recognition Award were looking for evidence of...

Early career researchers successfully awarded ACED funding

14 November 2022

Two early career researchers from the University of Cambridge have been awarded ACED Early Career Pathway awards in the latest round of funding announced by CRUK’s International Alliance for Cancer Early Detection (ACED).

EU cancer screening recommendations 2022

Screening more and screening better: New recommendations for cancer screening published by European Union

5 October 2022

Extended access to existing screening programmes and introduction of three new screening programmes are the recommendations made in the final report from the European Commission’s group of Chief Scientific Advisors, co-chaired by Early Cancer Institute Director Professor Rebecca Fitzgerald. The proposed Recommendation...

Harvey Dev awarded grant extension to further prostate cancer research

4 October 2022

Congratulations to Dr Harveer Dev who has been awarded a grant extension by Prostate Cancer Research to develop his new ProCASP tool, a CRISPR-Cas9 dynamic screening platform for prostate cancer.

Prof Sir Bruce Ponder toasts new Institute

Early Cancer Institute launched at the University of Cambridge

27 September 2022

Wednesday 21 st September saw the official launch of the Early Cancer Institute at the University of Cambridge. Located in the Hutchison building on the Cambridge biomedical campus, the Institute is the first physical location in the UK solely dedicated to research into Early Cancer. The launch event commenced with a lunch...

Inside the new institute looking at early cancer

21 September 2022

The Early Cancer Institute at the University of Cambridge aims to help create a world where we can detect cancer early enough to cure it. It is the first physical institute in the UK dedicated to understanding early cancer. As it hosts its official launch event, find out more about the pioneering research and the scientists within it.

Matt Hoare receives CRUK Programme Foundation Award to explore liver cancer development

20 September 2022

New grant will enable research into the link between chronic liver disease and liver cancer.

Charlie Massie wins Prostate Cancer UK research award

13 September 2022

Charlie Massie has been awarded a Prostate Cancer UK research award to investigate the epigenetic evolution of prostate cancer. Epigenetics is the study of how your own behaviours and environment can cause changes that affect the way your genes work, without changing our DNA. Epigenetics has been linked to a number of...

Interview with Professor Serena Nik-Zainal: Investigating the imprints of cancer

15 August 2022

Early Cancer Institute Group Leader, Professor Serena Nik-Zainal, is at the forefront of genomic research, creating tools for clinicians which are transforming patient care. She was recently interviewed for This Cambridge Life, a series of stories from the people that make Cambridge University unique.

Prostate cancer risk prediction algorithm could help target testing at men at greatest risk

Rebecca Fitzgerald receives Cancer Research Horizons Innovation and Entrepreneurship Award

Early career researchers successfully awarded ACED funding

Screening more and screening better: New recommendations for cancer screening published by European Union

Harvey Dev awarded grant extension to further prostate cancer research

Early Cancer Institute launched at the University of Cambridge

Inside the new institute looking at early cancer

Matt Hoare receives CRUK Programme Foundation Award to explore liver cancer development

Charlie Massie wins Prostate Cancer UK research award

Interview with Professor Serena Nik-Zainal: Investigating the imprints of cancer

Upcoming events

Contact Us

Quick Links

Connect with us

Study at Cambridge

About the University

Research at Cambridge